Teva Pharmaceutical Industries Ltd.
A leader in affordable generic drugs and innovative specialty treatments for complex diseases.
TEVA | TA
Overview
Corporate Details
- ISIN(s):
- US8816242098 (+1 more)
- LEI:
- 549300BAFGM4RC74ZJ94
- Country:
- Israel
- Address:
- 124 DVORA HANEVIA, 6944020 TEL AVIV
- Website:
- https://www.tevapharm.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical company with a dual focus on generic and innovative medicines. As a world leader in generics, the company develops, manufactures, and markets a broad portfolio of affordable prescription products. Simultaneously, its innovative pharmaceutical business is dedicated to the research and development of specialty treatments in key therapeutic areas, including neurology (such as migraine and movement disorders), immuno-oncology, and metabolic diseases. Teva's integrated model leverages its extensive generics capabilities to support the creation of novel therapies and improve patient access to essential medicines worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-10 01:11 |
Major Shareholding Notification
Immediate Report
|
English | 335.4 KB | ||
| 2025-09-10 01:11 |
Foreign Filer Report
Immediate Report
|
English | 36.3 KB | ||
| 2025-08-06 01:14 |
Major Shareholding Notification
Immediate Report
|
English | 338.5 KB | ||
| 2025-08-06 01:14 |
Foreign Filer Report
Immediate Report
|
English | 36.3 KB | ||
| 2025-08-06 01:13 |
Major Shareholding Notification
Immediate Report
|
English | 340.1 KB | ||
| 2025-08-06 01:13 |
Foreign Filer Report
Immediate Report
|
English | 36.3 KB | ||
| 2025-07-31 01:15 |
Quarterly Report
FORM 10Q-FINANCIAL STATEMENTS -Q2/25
|
English | 352.1 KB | ||
| 2025-07-31 01:15 |
Foreign Filer Report
FORM 10Q-FINANCIAL STATEMENTS -Q2/25
|
English | 36.5 KB | ||
| 2025-07-30 16:15 |
Earnings Release
Reports 2025 Second Quarter Financial Results
|
English | 4.6 MB | ||
| 2025-07-30 16:15 |
Foreign Filer Report
Reports 2025 Second Quarter Financial Results
|
English | 36.4 KB | ||
| 2025-07-30 16:09 |
Regulatory News Service
The company's financial results for the second quarter 2025 reported abroad
|
Hebrew (modern) | 62.5 KB | ||
| 2025-06-17 01:12 |
Director's Dealing
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Kalif Eliyahu…
|
English | 337.8 KB | ||
| 2025-06-17 01:12 |
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Kalif Eliyahu…
|
English | 36.3 KB | ||
| 2025-06-10 01:42 |
Director's Dealing
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Vergis Janet S
|
English | 337.4 KB | ||
| 2025-06-10 01:42 |
Foreign Filer Report
FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES-Vergis Janet S
|
English | 36.3 KB |
Automate Your Workflow. Get a real-time feed of all Teva Pharmaceutical Industries Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Teva Pharmaceutical Industries Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
